Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2014-04-01 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
CHANGES IN INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGES IN BOARD COMMITTEE MEMBERS
Board/Management Information Classification · 100% confidence The document is an announcement from a company listed on the Hong Kong Stock Exchange regarding changes in its board of directors and board committee members. It details the resignation of two independent non-executive directors and the appointment of two new independent non-executive directors, including their backgrounds, terms of appointment, and committee memberships. The content focuses exclusively on board and management changes without any financial data, earnings information, or other report types. The document length is 9461 characters, which is substantial and contains detailed information about management changes. Therefore, this document fits the category of Board/Management Information (MANG).
2014-04-01 English
Voluntary announcement - Update of development status of new pharmaceutical products
Capital/Financing Update Classification · 90% confidence The document is a voluntary announcement by the board of directors of Uni-Bio Science Group Limited regarding the development status of new pharmaceutical products. It provides detailed updates on clinical trials, regulatory approvals, and expected timelines for product approval by the China Food and Drug Administration (CFDA). The document is not a full financial report, audit report, or earnings release. It is not a regulatory filing or certification, nor is it a presentation or proxy solicitation. The content focuses on product development progress and business outlook related to pharmaceutical products, which fits the category of a Capital/Financing Update (CAP) as it relates to business development and potential impact on company performance. The document length is over 5,000 characters and contains substantive information rather than just an announcement of a report publication, so it is not an RPA. Therefore, the best classification is Capital/Financing Update (CAP).
2014-03-21 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings Classification · 100% confidence The document is an announcement from the board of directors regarding a change of address of the Hong Kong branch share registrar and transfer office. It does not contain any financial data, report content, or detailed management discussion. The document is short (1618 characters) and serves as a regulatory announcement about a corporate administrative change. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it does not mention any report release. The best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and miscellaneous filings that do not fit other categories.
2014-03-14 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks for a listed issuer, Uni-Bio Science Group Limited. It includes detailed information on share issues, repurchases, and confirmations of compliance with listing rules. The document is a regulatory disclosure specific to capital changes and share repurchases, not a full financial report or earnings release. It fits the definition of a Share Issue/Capital Change announcement, as it reports on new share issues and share buybacks with relevant details and dates. The document length is over 6000 characters and contains substantive data on share capital changes, confirming it is not merely an announcement of a report but the actual disclosure itself.
2014-03-12 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2014
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28 February 2014. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions. The content is focused on changes in the company's share capital structure and securities movements during a specific month. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is a regulatory filing reporting monthly share capital movements to the Hong Kong Exchanges and Clearing Limited. This type of document fits the category of Regulatory Filings (RNS) as it is a compliance report on share capital movements and does not constitute a financial report or announcement of a report publication.
2014-03-04 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions as of a specific date (28 February 2014). It includes details about executive directors, non-executive directors, independent non-executive directors, and committee memberships (Audit, Remuneration, Nomination Committees). There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, and no report publication announcements. The content is focused on board composition and governance structure. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes or details about the company's board of directors or senior management.
2014-02-28 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.